Meta Ads Compliance for Supplements and Wellness

there are two separate rulebooks operating on every supplement ad, and conflating them is how brands get in trouble. meta's advertising policies determine whether your ad is allowed to run on the platform. FTC substantiation requirements and FDA claim rules determine whether your marketing is legal at all. an ad can sail through meta review and still be an unlawful drug claim. an ad can be perfectly legal and still get rejected because it triggered the personal attributes classifier.

this covers both, at an operator level. it is not legal advice. supplement claims carry real regulatory exposure and you should have counsel review your claim set before it runs at scale.

the claim hierarchy

understand these three tiers and most of the confusion resolves.

1. 1.disease claims — statements that a product treats, prevents, cures, mitigates, or diagnoses a disease. these convert a supplement into an unapproved drug in the eyes of FDA. 'reduces inflammation from arthritis' is a disease claim. never usable.
2. 2.structure-function claims — statements about how an ingredient affects the normal structure or function of the body. 'supports joint comfort', 'supports healthy sleep'. these are permissible for supplements with substantiation and the standard disclaimer, and they're the working vocabulary of the category.
3. 3.general wellness and product claims — statements about the product itself: ingredients, sourcing, testing, form, dosage transparency, manufacturing standards. lowest risk, and in practice the highest-clearing on meta.

and layered on top: meta's personal attributes policy applies regardless of tier. a perfectly legal structure-function claim written in second person about the reader's condition still gets rejected.

what triggers rejection on meta specifically

• —personal attributes — 'do you suffer from bloating?' the classifier reads the implication that meta identified the viewer by a health condition.
• —weight loss claims and imagery — restricted category, 18+ minimum, no before/after, no numeric loss promises.
• —unrealistic or guaranteed outcomes — 'melt fat', 'guaranteed results', 'in 7 days'.
• —unsafe supplements — meta prohibits ads for certain substances entirely, including some steroid-adjacent and unapproved compounds. check the prohibited list before building a SKU strategy.
• —misleading before/after or dramatic imagery — including body comparison composition without labels.
• —false authority — 'doctor approved', 'FDA approved' (supplements are never FDA approved), fake certification badges.
• —destination mismatch — the landing page makes claims the ad avoided. crawled and caught.

$4.3M in spend to $19.1M in revenue, run inside these constraints. compliance is not the ceiling on supplement performance. creative volume and offer quality are.

compliant copy frameworks

four reliable patterns. use them as templates and swap the specifics.

1. 1.ingredient-and-dose transparency — 'every serving has 500mg of X, the amount used in the research. most brands use 50.' specific, product-focused, clears review.
2. 2.manufacturing and testing — 'made in a cGMP facility, third-party tested for identity, potency, and heavy metals. COA on every batch.'
3. 3.structure-function, product-subject — 'formulated to support healthy sleep cycles' rather than 'helps you sleep better.' the product is the subject; the reader isn't referenced.
4. 4.category education — explain a mechanism or a standard without applying it to the viewer. builds warm audiences you can retarget with offer creative.

and always run the second-person check: if the sentence tells the reader something about their own body, rewrite it. that single edit resolves most supplement disapprovals.

the disclaimer and substantiation layer

• —the FDA disclaimer for structure-function claims — that statements have not been evaluated by the FDA and the product is not intended to diagnose, treat, cure, or prevent disease — belongs on your product pages and packaging, prominently.
• —substantiation must exist before the claim runs. FTC requires competent and reliable scientific evidence. 'a study exists on the ingredient' is not automatically substantiation for your finished product's claim.
• —testimonials require that results be typical or that atypicality be disclosed clearly. burying that in fine print is exactly what enforcement targets.
• —influencer and affiliate content is your responsibility. claims made by creators you pay are attributable to you, and this is one of the most common enforcement gaps we see.
• —email and SMS carry the same claim rules as ads. a compliant ad feeding a non-compliant email sequence is still a claim problem.

how peptides differ from supplements

if you sell both, do not run them under the same claim strategy. supplements are regulated as food under DSHEA and permit structure-function claims. research-use-only peptides are not supplements, are not for human consumption, and permit no consumption-related claims whatsoever.

• —never apply structure-function language to an RUO product. 'supports recovery' about a research peptide is a human-use claim that collapses the RUO position.
• —keep the product lines on separate landing pages, ideally separate domains, with separate ad accounts.
• —the RUO catalog advertises on purity, testing, and logistics only.
• —the supplement catalog can advertise on structure-function within substantiation limits.
• —mixing them on one page is a common and serious mistake — it contaminates the compliance posture of both.

meta approving your ad is not a legal opinion. it means an automated system didn't flag it. the FTC does not review your ad account.

a pre-launch compliance checklist

1. 1.every claim mapped to a tier: disease, structure-function, or product. disease claims deleted.
2. 2.substantiation file assembled for every structure-function claim actually used.
3. 3.second-person body language stripped from all ad copy and headlines.
4. 4.creative reviewed frame by frame for body imagery, comparison composition, and on-screen claims.
5. 5.landing page carrying the FDA disclaimer, real policy pages, and no claims the ad avoided.
6. 6.testimonials audited for typicality and for disease language.
7. 7.affiliate and influencer briefs updated with the same claim rules.
8. 8.counsel review before scaled spend.